CN101999342B - Novel preparation method of yolk diluent - Google Patents

Novel preparation method of yolk diluent Download PDF

Info

Publication number
CN101999342B
CN101999342B CN2010102992906A CN201010299290A CN101999342B CN 101999342 B CN101999342 B CN 101999342B CN 2010102992906 A CN2010102992906 A CN 2010102992906A CN 201010299290 A CN201010299290 A CN 201010299290A CN 101999342 B CN101999342 B CN 101999342B
Authority
CN
China
Prior art keywords
tris
yolk
final concentration
solution
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2010102992906A
Other languages
Chinese (zh)
Other versions
CN101999342A (en
Inventor
周文忠
王丽霞
胡树香
李喜和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inner Mongolia saikexing reproductive biotechnology (Group) Limited by Share Ltd
Original Assignee
SAIKEXING REPRODUCTIVE BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAIKEXING REPRODUCTIVE BIOTECHNOLOGY Co Ltd filed Critical SAIKEXING REPRODUCTIVE BIOTECHNOLOGY Co Ltd
Priority to CN2010102992906A priority Critical patent/CN101999342B/en
Publication of CN101999342A publication Critical patent/CN101999342A/en
Application granted granted Critical
Publication of CN101999342B publication Critical patent/CN101999342B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Meat, Egg Or Seafood Products (AREA)

Abstract

The invention discloses a novel preparation method of yolk diluent, belonging to the field of animal reproductive biology. The novel preparation method comprises the following steps of: preparing yolk: preparing 4.6 times of Tris-A mother solution and 6 times of Tris-B mother solution and carrying out the aseptic filtration; diluting into 0.5 time of Tris-A mother solution and Tris-B mother solution with sterile water; respectively mixing with the yolk, stirring, standing, centrifuging and obtaining supernatant; respectively adjusting the concentration of the supernatant with 4.6 times of Tris-A mother solution and 6 times of Tris-B mother solution to obtain 1 time of Tris-A mother solution and Tris-B mother solution; and respectively adding antibiotic and sterile glycerin, adjusting the pH value and storing the mixture at 4DEG C for later use. The method omits the filtering step and is simple; fewer granules exist in the yolk diluent; and the method ensures the motility rate of cryopreservation sperms, improves the quality of froze sperm products and reduces the production cost.

Description

A kind of compound method of yolk diluent
Technical field:
The invention belongs to animal reproduction biological technical field, be applicable to that ox freezes the preparation of dilution in smart the production, a kind of compound method of yolk diluent mainly is provided.
Background technology:
Dilution is the main and necessary reagent during cow frozen semen is produced, and yolk diluent is widely used in the production of obstinacy control frozen semen because of sperm there being the better protection effect.The quality of a lot of granule foreign composition influence dilutions and the detection of product are arranged in the yolk diluent, mainly remove these impurity particles at present through the centrifugal filtration means that add.Because of containing a large amount of organic principles in the yolk, filter with the sterile filters of 0.22 μ m, not only take time and effort, and also with high costs, developed should technology for this reason.
Summary of the invention:
The present invention provides a kind of yolk diluent compound method that ox is frozen smart production that is used for; This know-why is to utilize salt ionic concentration that the gathering of particulate component in the yolk is played an important role; Low salt ionic concentration helps agglomeration of particles, thereby can so just can save the step of filtration through the most of particle of centrifugal removal; Reduce cost, use manpower and material resources sparingly.
The objective of the invention is to realize through following technical scheme: a kind of compound method of yolk diluent is characterized in that: it comprises the steps:
1) preparation of yolk: choose new fresh hen egg, with eggshell with 75% alcohol disinfecting, shell breaking, egg white under aseptic condition; Blot with the egg white of filter paper of sterilizing, extract yolk with asepsis injector with the vitellinae membrana surface;
2) preparation of 4.6 times of Tris-A and 6 times of Tris-B mother liquors:
Figure GSB00000897488200011
Figure GSB00000897488200021
Prepare 4.6 times of Tris-A mother liquors according to above-mentioned prescription with distilled water, 6 times of Tris-B mother liquors, adjust pH is 6.80 ± 0.02 respectively, filters with 0.22 μ m sterile filters;
3) preparation of 0.5 times of Tris-A solution and 0.5 times of Tris-B solution: using sterile water that 4.6 times of Tris-A mother liquors and 6 times of Tris-B mother liquors are diluted respectively is 0.5 times of Tris-A solution and 0.5 times of Tris-B solution, and the solution for preparing is preserved under 4 ℃ of environment, and is subsequent use;
4) preparation of Tris-A, Tris-B dilution
1. the preparation of Tris-A dilution
0.5 times of Tris-A solution and the yolk volume ratio by 7: 2 is added in the sterile chamber; Stirred 2 hours with 400-500 rev/min with magnetic stirring apparatus down in 4 ℃ of environment, leave standstill 20h again, then with 4 ℃ of supernatants, the centrifugal 60min of 3850g; Get supernatant; And press 4.6 times of Tris-A mother liquors of volume ratio adding of 1: 9.4, and shake up, add antibiotic: gentamicin final concentration 500 μ g/ml; Lincomycin final concentration 300 μ g/ml; Miramycin final concentration 600 μ g/ml; Tylosin final concentration 100 μ g/ml, adjust pH is 6.80 ± 0.02, in 4 ℃ of refrigerators, preserves subsequent use;
2. the preparation of Tris-B dilution
0.5 times of Tris-B solution and the yolk volume ratio by 7: 2.3 is added in the sterile chamber, in 4 ℃ of environment down with magnetic stirring apparatus with 400-500 rev/min of stirring 2 hours, leave standstill 20h again; With 4 ℃ of supernatants, the centrifugal 60min of 3850g, get supernatant then, and add 6 times of Tris-B mother liquors by 7: 93 volume ratio; Add aseptic glycerine again; The final ratio of glycerine is 12%v/v, shakes up, and adds antibiotic: gentamicin final concentration 26.6 μ g/ml; Lincomycin final concentration 15.9 μ g/ml; Miramycin final concentration 31.9 μ g/ml; Tylosin final concentration 5.3 μ g/ml, adjust pH is 6.80 ± 0.02, in 4 ℃ of refrigerators, preserves subsequent use.
A kind of yolk diluent freezes smart and conventional application of freezing in smart the production in the obstinacy control.
The invention has the beneficial effects as follows: this know-why is to utilize salt ionic concentration that the gathering of particulate component in the yolk is played an important role, and low salt ionic concentration helps agglomeration of particles, thereby can be through the most of particle of centrifugal removal; So just can save the step of filtration; This yolk diluent compound method is simple, and the yolk diluent particle that makes simultaneously is few, guarantees the motility rate of frozen sperm; Improved and frozen smart product quality, reduced production cost.
Description of drawings
Fig. 1 is that ox number 11103832 (X) use novel yolk diluent and former yolk dilution microscope figure.A: novel yolk diluent b: former yolk dilution.
Fig. 2 is that ox YE025 (X) uses novel yolk diluent and former yolk dilution microscope figure.A: novel yolk diluent b: former yolk dilution.
Fig. 3 is that ox number 11102390 (X) use novel yolk diluent and former yolk dilution microscope figure.A: novel yolk diluent b: former yolk dilution.
Embodiment
Embodiment: a kind ofly be used for the compound method that ox is frozen the smart yolk diluent of producing, it comprises the steps:
1, the preparation of yolk: choose new fresh hen egg, with the alcohol disinfecting of eggshell with 75% (v/v), shell breaking, egg white under aseptic condition blot with the egg white of filter paper with the vitellinae membrana surface of sterilizing, extract yolk with asepsis injector;
2, the preparation of 4.6 times of Tris-A and 6 times of Tris-B mother liquors:
Table 1 100ml 4.6 * Tris-A mother liquor prescription
Nomenclature of drug Weight (g)
Tris?base 16.25
Citric acid 7.92
D-Fructose 5.82
Table 2 100ml 6 * Tris-B mother liquor prescription
Nomenclature of drug Weight (g)
Tris?base 21.45
Citric acid 11.99
D-Fructose 8.83
With 4.6 times of Tris-A mother liquors of distilled water preparation, 6 times of Tris-B mother liquors, adjust pH is 6.80 ± 0.02 respectively, filters with 0.22 μ m sterile filters according to last table prescription;
3, the preparation of 0.5 times of Tris-A solution and 0.5 times of Tris-B solution: using sterile water that 4.6 times of Tris-A mother liquors and 6 times of Tris-B mother liquors are diluted respectively is 0.5 times of Tris-A solution and 0.5 times of Tris-B solution, and the solution for preparing preserves under 4 ℃ of environment, subsequent use;
4.Tris-A, the preparation of Tris-B dilution:
(1) preparation of Tris-A dilution
0.5 times of Tris-A solution and the yolk volume ratio by 7: 2 is added in the sterile chamber; Stirred 2 hours with 400-500 rev/min with magnetic stirring apparatus down in 4 ℃ of environment, after leaving standstill 20h under 4 ℃ of conditions, 4 ℃ of supernatants, the centrifugal 60min of 3850g; Get supernatant; And press 4.6 times of Tris-A mother liquors of volume ratio adding of 1: 9.4, and shake up, add antibiotic: gentamicin final concentration 500 μ g/ml; Lincomycin final concentration 300 μ g/ml; Miramycin final concentration 600 μ g/ml; Tylosin final concentration 100 μ g/ml, adjust pH is 6.80 ± 0.02, in 4 ℃ of refrigerators, preserves subsequent use;
(2) preparation of Tris-B dilution
0.5 times of Tris-B solution and the yolk volume ratio by 7: 2.3 is added in the sterile chamber, in 4 ℃ of environment down with magnetic stirring apparatus with 400-500 rev/min of stirring 2 hours, after leaving standstill 20h under 4 ℃ of conditions; With 4 ℃ of supernatants, the centrifugal 60min of 3850g, get supernatant, and add 6 times of Tris-B mother liquors by 7: 93 volume ratio; Add aseptic glycerine in proportion; The final ratio of glycerine is 12% (v/v), shakes up, and adds antibiotic: gentamicin final concentration 26.6 μ g/ml; Lincomycin final concentration 15.9 μ g/ml; Miramycin final concentration 31.9 μ g/ml; Tylosin final concentration 5.3 μ g/ml, adjust pH is 6.80 ± 0.02, in 4 ℃ of refrigerators, preserves subsequent use.
Application example 1: be numbered 11103832 stock bull X sperms with former dilution and novel dilution production; According to freezing smart flow process frozen semen (People's Republic of China's agricultural industry criteria; NY/T1234-2006); Behind the semen freezing 24h, detect seminal fluid each item quality index, comprising the back vigor that thaws, back 4h vigor, time-to-live and bacterial population thaw; The result shows that two kinds of yolk diluents are consistent to the back vigor that freezes, 4h vigor, the cryoprotection effect of time-to-live of same stock bull seminal fluid, and bacterial population does not have marked difference; And novel yolk diluent amounts of particles obviously is less than former yolk dilution.
The different yolk diluents of table 3 are to freezing the influence of extract Iuality
Yolk diluent Freeze the back vigor 4 hours vigor Time-to-live Bacterial population
New dilution 0.60 0.30 T=5.5 0
Former dilution 0.61 0.20 T=5.5 11
Application examples 2: be numbered YE025 stock bull X sperm with former dilution and novel dilution production; According to freezing smart flow process frozen semen; Behind the semen freezing 24h, detect seminal fluid each item quality index, comprising the back vigor that thaws, back 4h vigor, time-to-live and bacterial population thaw.The result shows that two kinds of yolk diluents are consistent to the back vigor that freezes, 4h vigor, the cryoprotection effect of time-to-live of same stock bull seminal fluid, and bacterial population does not have marked difference.And novel yolk diluent amounts of particles obviously is less than former yolk dilution.
The different yolk diluents of table 4 are to freezing the influence of extract Iuality
Yolk diluent Freeze the back vigor 4 hours vigor Time-to-live Bacterial population
New dilution 0.58 0.28 T=5 1
Former dilution 0.55 0.26 T=5.5 15
Application examples 3: be numbered 11102390 stock bull X sperms with former dilution and novel dilution production; According to freezing smart flow process frozen semen; Behind the semen freezing 24h, detect seminal fluid each item quality index, comprising the back vigor that thaws, back 4h vigor, time-to-live and bacterial population thaw.The result shows that two kinds of yolk diluents are consistent to the back vigor that freezes, 4h vigor, the cryoprotection effect of time-to-live of same stock bull seminal fluid, and bacterial population does not have marked difference.And novel yolk diluent amounts of particles obviously is less than former yolk dilution.
The different yolk diluents of table 5 are to freezing the influence of extract Iuality
Yolk diluent Freeze the back vigor 4 hours vigor Time-to-live Bacterial population
New dilution 0.54 0.20 T=5 3
Former dilution 0.55 0.27 T=5 0

Claims (1)

1. the compound method of a yolk diluent, it is characterized in that: it comprises the steps:
1) preparation of yolk: choose new fresh hen egg, with eggshell with 75% alcohol disinfecting, shell breaking, egg white under aseptic condition; Blot with the egg white of filter paper of sterilizing, extract yolk with asepsis injector with the vitellinae membrana surface;
2) preparation of 4.6 times of Tris-A and 6 times of Tris-B mother liquors:
Figure FSB00000897488100011
Prepare 4.6 times of Tris-A mother liquors according to above-mentioned prescription with distilled water, 6 times of Tris-B mother liquors, adjust pH is 6.80 ± 0.02 respectively, filters with 0.22 μ m sterile filters;
3) preparation of 0.5 times of Tris-A solution and 0.5 times of Tris-B solution: using sterile water that 4.6 times of Tris-A mother liquors and 6 times of Tris-B mother liquors are diluted respectively is 0.5 times of Tris-A solution and 0.5 times of Tris-B solution, and the solution for preparing is preserved under 4 ℃ of environment, and is subsequent use;
4) preparation of Tris-A, Tris-B dilution
1. the preparation of Tris-A dilution
0.5 times of Tris-A solution and the yolk volume ratio by 7: 2 is added in the sterile chamber; Stirred 2 hours with 400-500 rev/min with magnetic stirring apparatus down in 4 ℃ of environment, leave standstill 20h again, then with 4 ℃ of supernatants, the centrifugal 60min of 3850g; Get supernatant; And press 4.6 times of Tris-A mother liquors of volume ratio adding of 1: 9.4, and shake up, add antibiotic: gentamicin final concentration 500 μ g/ml; Lincomycin final concentration 300 μ g/ml; Miramycin final concentration 600 μ g/ml; Tylosin final concentration 100 μ g/ml, adjust pH is 6.80 ± 0.02, in 4 ℃ of refrigerators, preserves subsequent use;
2. the preparation of Tris-B dilution
0.5 times of Tris-B solution and the yolk volume ratio by 7: 2.3 is added in the sterile chamber, in 4 ℃ of environment down with magnetic stirring apparatus with 400-500 rev/min of stirring 2 hours, leave standstill 20h again; With 4 ℃ of supernatants, the centrifugal 60min of 3850g, get supernatant then, and add 6 times of Tris-B mother liquors by 7: 93 volume ratio; Add aseptic glycerine again; The final ratio of glycerine is 12%v/v, shakes up, and adds antibiotic: gentamicin final concentration 26.6 μ g/ml; Lincomycin final concentration 15.9 μ g/ml; Miramycin final concentration 31.9 μ g/ml; Tylosin final concentration 5.3 μ g/ml, adjust pH is 6.80 ± 0.02, in 4 ℃ of refrigerators, preserves subsequent use.
CN2010102992906A 2010-10-08 2010-10-08 Novel preparation method of yolk diluent Active CN101999342B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102992906A CN101999342B (en) 2010-10-08 2010-10-08 Novel preparation method of yolk diluent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102992906A CN101999342B (en) 2010-10-08 2010-10-08 Novel preparation method of yolk diluent

Publications (2)

Publication Number Publication Date
CN101999342A CN101999342A (en) 2011-04-06
CN101999342B true CN101999342B (en) 2012-11-07

Family

ID=43807230

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102992906A Active CN101999342B (en) 2010-10-08 2010-10-08 Novel preparation method of yolk diluent

Country Status (1)

Country Link
CN (1) CN101999342B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103518706B (en) * 2013-10-21 2015-04-01 西北农林科技大学 Diluent of frozen semen of milk goat, and preparation method and diluting method thereof as well as preparation method of frozen semen of milk goat in thin pipe
CN105285665A (en) * 2015-10-25 2016-02-03 钟静涛 Fishiness removing method of egg powder
CN106538511A (en) * 2016-09-30 2017-03-29 马伟 A kind of manufacture method of antioxidative sheep freezing seminal fluid dilution

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927226A (en) * 2006-09-11 2007-03-14 华中农业大学 Cow sex-control sperm freezing preservation seminal fluid dilution
CN101167747A (en) * 2007-10-16 2008-04-30 上海金晖家畜遗传开发有限公司 Bull semen diluent and its configuration method and adding method
CN101411722A (en) * 2008-10-22 2009-04-22 李喜和 Freezing mixed sperm for controlling X/Y gender of milk cattle and preparation method thereof
CN101554152A (en) * 2009-05-21 2009-10-14 西北农林科技大学 Frozen semen diluent and preparation method thereof
CN101810163A (en) * 2010-05-10 2010-08-25 广西大学 Method for freezing semen of Macaca fascicularis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927226A (en) * 2006-09-11 2007-03-14 华中农业大学 Cow sex-control sperm freezing preservation seminal fluid dilution
CN101167747A (en) * 2007-10-16 2008-04-30 上海金晖家畜遗传开发有限公司 Bull semen diluent and its configuration method and adding method
CN101411722A (en) * 2008-10-22 2009-04-22 李喜和 Freezing mixed sperm for controlling X/Y gender of milk cattle and preparation method thereof
CN101554152A (en) * 2009-05-21 2009-10-14 西北农林科技大学 Frozen semen diluent and preparation method thereof
CN101810163A (en) * 2010-05-10 2010-08-25 广西大学 Method for freezing semen of Macaca fascicularis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
不同种公牛X/Y精子分离效果及对体外受精能力的影响;吴冬生等;《中国奶牛》;20091231(第4期);第11-15页 *
吴冬生等.不同种公牛X/Y精子分离效果及对体外受精能力的影响.《中国奶牛》.2009,(第4期),第11-15页.

Also Published As

Publication number Publication date
CN101999342A (en) 2011-04-06

Similar Documents

Publication Publication Date Title
CN103478509B (en) Production method of bacillus amyloliquefaciens antimicrobial lipopeptide and application thereof in prawn feed
CN102894186B (en) Albumen powder richening in antimicrobial peptide fly maggot, preparation method for albumen powder and feed additive of albumen powder
CN103548812B (en) Normal-temperature and low-temperature preservation diluents of milk goat seminal fluid
CN102311919B (en) Microalgae species preserving method
CA3053617A1 (en) New fermentation medium for growth of methanotrophic bacteria and method for producing said medium
CN112931491B (en) Hexagrammos otakii sperm low-temperature preservation liquid
CN103222458A (en) Swine gender-controlling sperm and preparation method and application thereof
CN101999342B (en) Novel preparation method of yolk diluent
CN103070162B (en) Muscovy duck semen diluent
CN106701583B (en) Method for preserving chlorella in seawater
CN104322483A (en) Boar antiviral long-acting semen diluent formula and preparation method
CN112655822A (en) Feed additive for livestock and poultry, preparation method and application thereof
CN103651330A (en) Animal semen preservative with biological activity and preparation method thereof
CN105684974A (en) Breeding medium used for juvenile shrimp and crab pool and preparation method of breeding medium
CN111345308A (en) Preparation for strongly removing vibrios and preparation method thereof
CN104082276A (en) Zinc-containing sheep seminal fluid diluting storage liquid and preparation method thereof
CN102246747A (en) Semen diluter and preparation method as well as application method thereof
CN109279632B (en) Preparation method and application of hydroxyl magnesium chloride
CN112514891B (en) Panda latex frozen stock solution and panda latex preservation method
CN107232184B (en) Diluent for preserving semen of black pig in Guanzhong at normal temperature
CN102132708A (en) Bacteriostat from Jatropha curcas and bacteriostasis application thereof in planting edible mushrooms
CN108812646A (en) A kind of stored refrigerated dilution of dog sperm
CN106342786A (en) Diluent for in-vitro low temperature preservation of boar semen and preparation method thereof
CN102711515B (en) Chlorella suspension for sea feed comprising extract of lotus leaf
CN111657263A (en) Animal semen diluting powder and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Address after: 011517 the Inner Mongolia Autonomous Region Helingeer County of Hohhot city Shengle Economic Zone Development Avenue North Building 6 floor of Mengniu

Applicant after: Saikexing Reproductive Biotechnology CO., Ltd.

Address before: 011517 the Inner Mongolia Autonomous Region Helingeer County of Hohhot city Shengle Economic Zone Development Avenue North Building 6 floor of Mengniu

Applicant before: Mengniu Reproductive Biltechnology Co., Ltd.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: INNER MONGOLIA MENGNIU REPRODUCTIVE BIOTECHNOLOGY CO., LTD. TO: INNER MONGOLIA SEXING REPRODUCTIVE BIOTECHNOLOGY CO., LTD.

C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: INNER MONGOLIA SKXING REPRODUCTIVE BIOTECHNOLOGY (

Free format text: FORMER NAME: INNER MONGOLIA SEXING REPRODUCTIVE BIOTECHNOLOGY CO., LTD.

CP03 Change of name, title or address

Address after: 011517 the Inner Mongolia Autonomous Region Helingeer County of Hohhot city Shengle economic Park gathering service area management committee building 4 New South Building Room 4422

Patentee after: Inner Mongolia saikexing reproductive biotechnology (Group) Limited by Share Ltd

Address before: 011517 the Inner Mongolia Autonomous Region Helingeer County of Hohhot city Shengle Economic Zone Development Avenue North Building 6 floor of Mengniu

Patentee before: Saikexing Reproductive Biotechnology CO., Ltd.